COLLEEN PAGOADA: Open Payments
NPI 1497596480 · PANAMA CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$539 in 25 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $457 · 2025 $539
Food & beverage: $480Education: $59
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $89 |
| Alkermes, Inc. | 2 | $75 |
| Vanda Pharmaceuticals Inc. | 4 | $72 |
| Lundbeck LLC | 3 | $64 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $61 |
| Janssen Pharmaceuticals, Inc | 3 | $60 |
| Indivior Inc. | 2 | $35 |
| Novo Nordisk Inc | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
Products named: VRAYLAR, FANAPT, REXULTI, TRINTELLIX, SPRAVATO, VIVITROL, SUBLOCADE, Wegovy.
Industry payments across FL — which companies pay providers there.
